Excision BioTherapeutics Licenses New CRISPR Systems from UC Berkeley

Excision BioTherapeutics has become the first company to exclusively license new  CRISPR  systems discovered last year by Jennifer Doudna, Ph.D., a pioneer of the gene-editing technology, and Jillian Banfield, Ph.D., for use in developing treatments against infectious diseases.   Excision has licensed the new CRISPR (clustered regularly interspaced short palindromic repeats) systems for use from the University of California, Berkeley, under an agreement announced today, and whose